Nutrition

Better Choice Company, Inc. Announces Second Quarter 2023 Results

Enhanced Operational and Financial Discipline33% Growth in EPS Year-Over-YearGross Margin Growth of 543 Basis Points Year-Over-YearOperating Margin Growth of 127…

1 year ago

Preliminary Clinical Trial Presentation for Stem Cell and Dementia Held by Beauty-Stem Biomedical and Tzu Chi Hospital in Los Angeles, CA

First stem cell clinical trial landscape is revolutionized by Beauty-Stem Biomedical and Taiwan Tzu Chi Hospital, unveiling the progress of…

1 year ago

Found Joins the Innovators’ Network at American Heart Association Center for Health Technology & Innovation as the First Medical Weight Loss Solution Member

American Heart Association consortium advances development of evidence-based health tech solutionsAUSTIN, Texas--(BUSINESS WIRE)--Found, a medically-assisted weight loss program, today announced…

1 year ago

CYCLE Kids Launches Brooklyn-Based Fundraising Campaign

Non-profit to Kick Off Back-to-School Campaign with a Times Square Billboard on National Non-Profit Day CYCLE Kids A Bike Can…

1 year ago

Stemtech Announces China Market Expansion

Stemtech Unveils Bold Vision ‘Grand China Market Plan' to Supercharge China's Thriving Health and Wellness Landscape Amidst $ 683 Billion…

1 year ago

Panbela Announces Issuance of New Patent in Europe for Claims of a Novel Process for the Production of SBP-101

Patent developed in collaboration with Syngene International Ltd.MINNEAPOLIS, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a…

1 year ago

Smart for Life to Exhibit Greens First Products at The National Convention by the Florida Chiropractic Association

Newly Launched Greens First Protein Bars to be Showcased at the World’s Largest Event for the Chiropractic Profession Smart for…

1 year ago

CorVive Athlete Soars at the World Triathlon Age Group Championships in Hamburg

PLANO, TX / ACCESSWIRE / August 10, 2023 / CorVive, a leading company in the health and wellness industry, is…

1 year ago

Napo Pharmaceuticals, a Jaguar Health Company, Announces Activation by FDA of Investigational New Drug (IND) Application for Crofelemer for Treatment of Microvillus Inclusion Disease

MVID is a life-threatening and ultra-rare autosomal recessive disease that affects newborns and children, leading to intestinal failure, significant morbidity…

1 year ago